Evaluation of extracellular matrix protein CCN1 as a prognostic factor for glioblastoma

Joji Ishida, Kazuhiko Kurozumi, Tomotsugu Ichikawa, Yoshihiro Otani, Manabu Onishi, Kentaro Fujii, Yosuke Shimazu, Tetsuo Oka, Toshihiko Shimizu, Isao Date

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Recently, research efforts in identifying prognostic molecular biomarkers for malignant glioma have intensified. Cysteine-rich protein 61 (CCN1) is one of the CCN family of matricellular proteins that promotes cell growth and angiogenesis in cancers through its interaction with several integrins. In this study, we investigated the relationships among CCN1, O6-methylguanine-DNA methyltransferase expression, the tumor removal rate, and prognosis in 46 glioblastoma patients treated at the Okayama University Hospital. CCN1 expression was high in 31 (67 %) of these patients. The median progression-free survival (PFS) and overall survival (OS) times of patients with high CCN1 expression was significantly shorter than those of patients with low CCN1 expression (p < 0.005). In a multivariate Cox analysis, CCN1 proved to be an independent prognostic factor for patient survival [PFS, hazard ratio (HR) = 3.53 (1.55–8.01), p = 0.003 and OS, HR = 3.05 (1.35–6.87), p = 0.007]. Moreover, in the 31 patients who underwent gross total resection, the PFS and OS times of those with high CCN1 expression were significantly shorter than those with low CCN1 expression. It was concluded that CCN1 might emerge as a significant prognostic factor regarding the prognosis of glioblastoma patients.

Original languageEnglish
Pages (from-to)245-252
Number of pages8
JournalBrain tumor pathology
Volume32
Issue number4
DOIs
Publication statusPublished - Oct 1 2015

Keywords

  • CCN1
  • Glioma
  • MGMT
  • Prognostic marker

ASJC Scopus subject areas

  • Oncology
  • Clinical Neurology
  • Cancer Research

Fingerprint Dive into the research topics of 'Evaluation of extracellular matrix protein CCN1 as a prognostic factor for glioblastoma'. Together they form a unique fingerprint.

  • Cite this